Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panda Pharmaceutical Industries is a prominent Egyptian pharmaceutical company established in 2005 and headquartered in 6th of October City. The company specializes in the development, manufacturing, and marketing of a diverse range of branded generic medications across multiple therapeutic areas, including anti-infectives, respiratory, gastrointestinal, and central nervous system health. Panda Pharma operates a state-of-the-art manufacturing facility that adheres to international quality standards, enabling it to serve the domestic Egyptian market and various export markets in the MENA region. Its product portfolio includes well-known brands such as Pandaclav, Pandavir, and Pandaflex, focusing on providing high-quality and affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panda Pharmaceuticals.